DrugPatentWatch Database Preview
Novel Labs Inc Company Profile
What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?
NOVEL LABS INC has fifty-eight approved drugs.
There are two tentative approvals on NOVEL LABS INC drugs.
Summary for Novel Labs Inc
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 43 |
| NDAs: | 58 |
Drugs and US Patents for Novel Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novel Labs Inc | VORICONAZOLE | voriconazole | FOR SUSPENSION;ORAL | 206799-001 | May 31, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novel Labs Inc | CLOBETASOL PROPIONATE | clobetasol propionate | SOLUTION;TOPICAL | 206075-001 | Nov 23, 2015 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novel Labs Inc | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 091077-001 | Oct 6, 2009 | OTC | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Novel Labs Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 204603-001 | Apr 29, 2015 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novel Labs Inc | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | CAPSULE;ORAL | 204746-001 | Dec 30, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
